Terms: = Colorectal cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Clinical Outcome
11 results:
1. Activating IL-6/stat3 Enhances Protein Stability of Proteasome 20S
Ren W; Zhang X; Li Q; Pu C; Zhang D
Biomed Res Int; 2022; 2022():4250013. PubMed ID: 35615012
[TBL] [Abstract] [Full Text] [Related]
2. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
[TBL] [Abstract] [Full Text] [Related]
3. Laminin 521 enhances self-renewal via stat3 activation and promotes tumor progression in colorectal cancer.
Qin Y; Shembrey C; Smith J; Paquet-Fifield S; Behrenbruch C; Beyit LM; Thomson BNJ; Heriot AG; Cao Y; Hollande F
Cancer Lett; 2020 Apr; 476():161-169. PubMed ID: 32105676
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/stat3 pathway.
Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.
Rokavec M; Kaller M; Horst D; Hermeking H
Sci Rep; 2017 Jul; 7(1):4687. PubMed ID: 28680090
[TBL] [Abstract] [Full Text] [Related]
6. Steering of carcinoma progression by the YIN/YANG interaction of STAT1/stat3.
Friedrich K; Dolznig H; Han X; Moriggl R
Biosci Trends; 2017 Mar; 11(1):1-8. PubMed ID: 28154246
[TBL] [Abstract] [Full Text] [Related]
7. The ratio of STAT1 to stat3 expression is a determinant of colorectal cancer growth.
Nivarthi H; Gordziel C; Themanns M; Kramer N; Eberl M; Rabe B; Schlederer M; Rose-John S; Knösel T; Kenner L; Freund P; Aberger F; Han X; Kralovics R; Dolznig H; Jennek S; Friedrich K; Moriggl R
Oncotarget; 2016 Aug; 7(32):51096-51106. PubMed ID: 27191495
[TBL] [Abstract] [Full Text] [Related]
8. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
Schweiger T; Kollmann D; Nikolowsky C; Traxler D; Guenova E; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Eur J Cardiothorac Surg; 2014 Jul; 46(1):92-9. PubMed ID: 24321995
[TBL] [Abstract] [Full Text] [Related]
9. RKIP phosphorylation and stat3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
[TBL] [Abstract] [Full Text] [Related]
10. Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression.
Wang Y; Velho S; Vakiani E; Peng S; Bass AJ; Chu GC; Gierut J; Bugni JM; Der CJ; Philips M; Solit DB; Haigis KM
Cancer Discov; 2013 Mar; 3(3):294-307. PubMed ID: 23274911
[TBL] [Abstract] [Full Text] [Related]
11. stat3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.
Morikawa T; Baba Y; Yamauchi M; Kuchiba A; Nosho K; Shima K; Tanaka N; Huttenhower C; Frank DA; Fuchs CS; Ogino S
Clin Cancer Res; 2011 Mar; 17(6):1452-62. PubMed ID: 21310826
[TBL] [Abstract] [Full Text] [Related]
